Guy Spigelman is the EMEA lead for Healthcare and Life Sciences Startups at Amazon Web Services (AWS). In this role Guy harnesses the technology and people at AWS to work alongside the investors and founders of startups to accelerate their scientific, engineering and commercial development. Recently Guy was instrumental in launching the AION Labs Consortium, an innovation lab focused on applying AI to solve core R&D Challenges in the pharma industry. Prior to AWS, Guy was VP Portfolio Success at aMoon, Israel’s largest health-technology VC and before that he led the entrepreneurship program at the Weizmann Institute, Israel’s pre-eminent biotech research center. Guy has been part of the leadership team of several early-stage startups, including XMPie sold to Xerox and AposTherapy where Guy launched global operations in EMEA and APAC.
Sweeden
Mats Hansson
Senior Professor of Biomedical Ethics at the Centre for Research Ethics & Bioethics, Uppsala University
Coordinator and Academic Lead of the IMI-project PREFER (2016-2022)
